Related references
Note: Only part of the references are listed.Urinary Excretion of Liver Type Fatty Acid Binding Protein Accurately Reflects the Degree of Tubulointerstitial Damage
Takeshi Yokoyama et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Tubular and Glomerular Injury in Diabetes and the Impact of ACE Inhibition
Stine E. Nielsen et al.
DIABETES CARE (2009)
Relationship between risk factors and mortality in type 1 diabetic patients in Europe - The EURODIAB Prospective Complications Study (PCS)
Sabita S. Soedamah-Muthu et al.
DIABETES CARE (2008)
Decreased urinary concentration of Tamm-Horsfall protein is associated with development of renal failure and cardiovascular death within 20 years in type 1 but not in type 2 diabetic patients
Ilir Sejdiu et al.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2008)
Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy
T Nakamura et al.
DIABETES CARE (2005)
Clinical evaluation of urinary excretion of liver-type fatty acid-binding protein as a marker for the monitoring of chronic kidney disease: A multicenter trial
A Kamijo et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2005)
Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules
A Kamijo et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study
P Hovind et al.
BRITISH MEDICAL JOURNAL (2004)
Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes
P Hovind et al.
DIABETES CARE (2003)
Fatty-acid-binding proteins do not protect against induced cytotoxicity in a kidney cell model
AW Zimmerman et al.
BIOCHEMICAL JOURNAL (2001)
Share Paper
